Skip to main content
. 2021 Jun 25;8:688369. doi: 10.3389/fnut.2021.688369

Table 3.

Association between DII, PTH, and HP, weighted.

β/ORa (95% CIb), P value
Model 1c Model 2d Model 3e
Parathyroid hormone
DII (continuous) 0.71 (0.51, 0.90)
<0.0001
0.58 (0.38, 0.77)
<0.0001
0.46 (0.25, 0.66)
<0.0001
DII categories
Tertile 1 Reference Reference Reference
Tertile 2 2.33 (1.09, 3.56)
0.0002
1.77 (0.54, 2.99)
0.0049
1.56 (0.28, 2.84)
0.0167
Tertile 3 4.11 (2.84, 5.39)
<0.0001
3.31 (2.03, 4.60)
<0.0001
2.66 (1.31, 4.01)
0.0001
Hyperparathyroidism
DII (continuous) 1.07 (1.05, 1.10)
<0.0001
1.07 (1.04, 1.09)
<0.0001
1.05 (1.02, 1.08)
0.0023
DII categories
Tertile 1 Reference Reference Reference
Tertile 2 1.48 (1.26, 1.75)
<0.0001
1.43 (1.21, 1.68)
<0.0001
1.27 (1.05, 1.55)
0.0157
Tertile 3 1.57 (1.33, 1.85)
<0.0001
1.49 (1.26, 1.76)
<0.0001
1.32 (1.09, 1.61)
0.0054

Insensitivity analysis—dietary inflammatory index was converted from a continuous variable to a categorical variable (tertiles).

a

β: effect sizes; OR: odds ratio.

b

95% CI: 95% confidence interval.

c

Model 1: no covariates were adjusted.

d

Model 2: adjusted for gender, age, and race.

e

Model 3: adjusted for gender, age, race, education level, serum glucose, serum calcium, serum phosphorus, serum iron, serum C-reactive protein serum, serum 25(OH)D, systolic blood pressure, diastolic blood pressure, body mass index, hypertension, diabetes, chronic kidney disease, protein intake, calcium intake, and phosphorus intake.